We demonstrated that HOTAIRM1 is upregulated in lenvatinib-resistant HCC cells and knockdown of HOTAIRM1 significantly increases lenvatinib sensitivity in HCC. Here, HOTAIRM1 is linked to hepatocellular carcinoma.